Squamous neoplasia of the scrotum: A series of 29 cases

American Journal of Surgical Pathology

Volumn 38, Issue 7, 2014, Pages 973-981

  Matoso, Andres ^a   Ross, Hillary M ^a   Chen, Sonja ^c   Allbritton, Jill ^b   Epstein, Jonathan I ^a  

^a JOHNS HOPKINS HOSPITAL   (United States)

^b Miraca Life Sciences   (United States)

^c RHODE ISLAND HOSPITAL   (United States)

Author keywords

HPV; p16; scrotal cancer; squamous cell carcinoma

Indexed keywords

CYCLIN DEPENDENT KINASE INHIBITOR 2A; KI 67 ANTIGEN; PROTEIN P53; TP53 PROTEIN, HUMAN; TUMOR MARKER; VIRUS DNA;

ADULT; AGED; ARTICLE; CHEMISTRY; COMORBIDITY; ETHNOLOGY; GENETICS; HUMAN; HUMAN PAPILLOMAVIRUS DNA TEST; IMMUNOHISTOCHEMISTRY; IN SITU HYBRIDIZATION; ISOLATION AND PURIFICATION; MALE; MALE GENITAL TRACT TUMOR; METASTASIS; MIDDLE AGED; MINIMAL RESIDUAL DISEASE; MULTICENTER STUDY; PAPILLOMA VIRUS; PATHOLOGY; REOPERATION; RISK FACTOR; SCROTUM; SQUAMOUS CELL CARCINOMA; TIME; TREATMENT OUTCOME; TUMOR RECURRENCE; UNITED STATES; VIROLOGY;

ADULT; AGED; CARCINOMA, SQUAMOUS CELL; COMORBIDITY; CYCLIN-DEPENDENT KINASE INHIBITOR P16; DNA, VIRAL; GENITAL NEOPLASMS, MALE; HUMAN PAPILLOMAVIRUS DNA TESTS; HUMANS; IMMUNOHISTOCHEMISTRY; IN SITU HYBRIDIZATION; KI-67 ANTIGEN; MALE; MIDDLE AGED; NEOPLASM RECURRENCE, LOCAL; NEOPLASM, RESIDUAL; PAPILLOMAVIRIDAE; REOPERATION; RISK FACTORS; SCROTUM; TIME FACTORS; TREATMENT OUTCOME; TUMOR MARKERS, BIOLOGICAL; TUMOR SUPPRESSOR PROTEIN P53; UNITED STATES;

EID: 84902553927     PISSN: 01475185     EISSN: 15320979     Source Type: Journal    
DOI: 10.1097/PAS.0000000000000192     Document Type: Article

References (34)

1. Graves RC, Flo S. Carcinoma of the scrotum. J Urol. 1940;43: 309-310.
2. Cruickshank CN, Squire Jr. Skin cancer in the engineering industry from the use of mineral oil. Br J Ind Med. 1950;7: 1-11.
3. Lione JG, Denholm JS. Cancer of the scrotum in wax pressmen. II. Clinical observations. AMA Arch Ind Health. 1959;19: 530-539.
4. Avellan L, Breine U, Jacobsson B, et al. Carcinoma of scrotum induced by mineral oil. Scand J Plast Reconstr Surg. 1967;1: 135-140.
5. Lee WR, McCann JK. Mule spinners' cancer and the wool industry. Br J Ind Med. 1967;24: 148-151.
6. Castiglione FM Jr, Selikowitz SM, Dimond RL. Mule spinner's disease. Arch Dermatol. 1985;121: 370-372.
7. Shifrin DA, Lange MK, Kahnoski RJ, et al. Squamous cell carcinoma of the scrotum in a radiation technologist and the use of sentinel lymph node biopsy in recurrent disease. Am Surg. 2007;73: 302-303.
8. Taniguchi S, Furukawa M, Kutsuna H, et al. Squamous cell carcinoma of the scrotum. Dermatology. 1996;193: 253-254.
9. Andrews PE, Farrow GM, Oesterling JE. Squamous cell carcinoma of the scrotum: long-term followup of 14 patients. J Urol. 1991;146: 1299-1304.
10. Schneider PR, Pribaz J, Russell RC. Microvenous graft length determination for arterial repair. Ann Plast Surg. 1986;17: 292-298.
11. Chintamani, Shankar M, Singhal V, et al. Squamous cell carcinoma developing in the scar of Fournier's gangrene-case report. BMC Cancer. 2004;4:16.
12. Kotwal S, Madaan S, Prescott S, et al. Unusual squamous cell carcinoma of the scrotum arising from a well healed, innocuous scar of an infertility procedure: a case report. Ann R Coll Surg Engl. 2007;89:W17-W19.
13. Abhyankar SV, Kulkarni A, Kulkarni M, et al. Squamous cell carcinoma of the penis and scrotum in a patient with chronic scrotal and penile lymphedema. Indian J Dermatol. 2010;55: 387-389.
14. Johnson TV, Hsiao W, Delman KA, et al. Scrotal cancer survival is influenced by histology: a SEER study. World J Urol. 2013;31: 585-590.
15. Velazquez EF, Chaux A, Cubilla AL. Histologic classification of penile intraepithelial neoplasia. Semin Diagn Pathol. 2012;29: 96-102.
16. Verhoeven RH, Kiemeney LA, Coebergh JW, et al. Occupation and scrotal cancer: results of the NOCCA study. Acta Oncol. 2011;50: 1244-1246.
17. Verhoeven RH, Aben KK, van Rossum MM, et al. New insights into the aetiology of scrotal cancer, a nationwide case-control study in the Netherlands. J Eur Acad Dermatol Venereol. 2014;28: 65-71.
18. Guran S, Pak I. Cumulation of TP53 mutations and p16INK4A/ p15INK4B homozygous deletions in human papilloma virus type 16 positive scrotal cancer. Cancer Genet Cytogenet. 1999;109: 108-113.
19. Kong CS, Balzer BL, Troxell ML, et al. p16INK4A immunohistochemistry is superior to HPV in situ hybridization for the detection of high-risk HPV in atypical squamous metaplasia. Am J Surg Pathol. 2007;31: 33-43.
20. Keating JT, Cviko A, Riethdorf S, et al. Ki-67, cyclin E, and p16INK4 are complimentary surrogate biomarkers for human papilloma virusrelated cervical neoplasia. Am J Surg Pathol. 2001;25: 884-891.
21. Agoff SN, Lin P, Morihara J, et al. p16(INK4a) expression correlates with degree of cervical neoplasia: a comparison with Ki- 67 expression and detection of high-risk HPV types. Mod Pathol. 2003;16: 665-673.
22. Sano T, Oyama T, Kashiwabara K, et al. Expression status of p16 protein is associated with human papillomavirus oncogenic potential in cervical and genital lesions. Am J Pathol. 1998;153: 1741-1748.
23. Mannweiler S, Sygulla S, Winter E, et al. Two major pathways of penile carcinogenesis: HPV-induced penile cancers overexpress p16ink4a, HPV-negative cancers associated with dermatoses express p53, but lack p16ink4a overexpression. J Am Acad Dermatol. 2013; 69: 73-81.
24. Chaux A, Pfannl R, Rodriguez IM, et al. Distinctive immunohistochemical profile of penile intraepithelial lesions: a study of 74 cases. Am J Surg Pathol. 2011;35: 553-562.
25. Kayes O, Ahmed HU, Arya M, et al. Molecular and genetic pathways in penile cancer. Lancet Oncol. 2007;8: 420-429.
26. Rubin MA, Kleter B, Zhou M, et al. Detection and typing of human papillomavirus DNA in penile carcinoma: evidence for multiple independent pathways of penile carcinogenesis. Am J Pathol. 2001; 159: 1211-1218.
27. Abell MR. Intraepithelial carcinomas of epidermis and squamous mucosa of vulva and perineum. Surg Clin North Am. 1965;45: 1179-1198.
28. Heller DS, van Seters M, Marchitelli C, et al. Update on intraepithelial neoplasia of the vulva: proceedings of a Workshop at the 2009 World Congress of the International Society for the Study of Vulvovaginal Diseases, Edinburgh, Scotland, September 2009. J Low Genit Tract Dis. 2010;14: 363-373.
29. Scurry J, Wilkinson EJ. Review of terminology of precursors of vulvar squamous cell carcinoma. J Low Genit Tract Dis. 2006;10: 161-169.
30. Ordi J, Alejo M, Fuste V, et al. HPV-negative vulvar intraepithelial neoplasia (VIN) with basaloid histologic pattern: an unrecognized variant of simplex (differentiated) VIN. Am J Surg Pathol. 2009;33: 1659-1665.
31. Protzel C, Knoedel J, Zimmermann U, et al. Expression of proliferation marker Ki67 correlates to occurrence of metastasis and prognosis, histological subtypes and HPV DNA detection in penile carcinomas. Histol Histopathol. 2007;22: 1197-1204.
32. Meyer T, Kunz M, Arndt R, et al. Detection of human papillomavirus type 35 in a nodular cutaneous tumor in a patient infected with human immunodeficiency virus. Clin Infect Dis. 1998; 26: 507-508.
33. Schmitz MW, Goldberg LJ, Adler AJ. An extensive case of Bowen's disease in an HIV-positive male. AIDS Patient Care STDS. 2007;21: 78-80.
34. Ioffe YJ, Erickson BK, Foster KE, et al. Low yield of residual vulvar carcinoma and dysplasia upon re-excision for close or positive margins. Gynecol Oncol. 2013;129: 528-532.